CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
March 5th 2024, 10:00pm
Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed.
March 3rd 2024, 6:00pm
After reading about breast cancer and aromatase inhibitors, a light went on for me about my leiomyosarcoma diagnosis.
February 27th 2024, 2:00pm
Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.
January 5th 2024, 4:00pm
From Shannen Doherty discussing in-vitro fertilization before breast cancer to "Chickadee" Cardwell's cancer experience to be featured on an upcoming TV series, here's what's happening in the oncology space this week.
December 18th 2023, 10:00pm
After being diagnosed with stage 3 liposarcoma, my life’s choices came sharply into focus.
November 3rd 2023, 9:00pm
When I was diagnosed with a rare cancer at the “stump” of my appendix, I was surprised, considering I had my appendix removed more than a decade ago.
November 2nd 2023, 1:00pm
I was diagnosed with a rare cancer in 2007, and it shaped who I am today.
October 18th 2023, 10:00pm
After multiple cancer surgeries, I'm now more confident than I was when I was living on "easy street."
September 22nd 2023, 7:00pm
Mohs micrographic surgery offered better survival outcomes for patients with early-stage Merkel cell carcinoma, compared with wide local excision.
September 21st 2023, 9:00pm
Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.
NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial
Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma